|
| |
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online September 23, 2003
Review Article |
Trends in antimalarial drug deployment in sub-Saharan Africa
Malaria Epidemiology Branch, Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
* Author for correspondence (e-mail: Pbloland{at}cdc.gov)
Accepted 18 July 2003
Antimalarial drug resistance is forcing newly developed pharmaceuticals into widespread use at an accelerating pace. To have the greatest public health impact, new pharmaceuticals will need to be deployed effectively in sub-Saharan Africa. Achieving effective antimalarial drug deployment over the short- to medium-term will require an appreciation of how drugs are currently used in Africa and the development of innovative approaches to optimize that use. Over the long-term, fundamental changes in the way that drugs are deployed will probably be required. There are many new strategies and initiatives that, to a greater or lesser degree, will influence how drugs are used. These influences may have a positive or negative effect on reducing malaria morbidity and mortality. The concept of analyzing and monitoring programmatic effectiveness allows for a more holistic understanding of these influences and allows for more unbiased, evidence-based decision making related to drug policy and deployment.
Key words: antimalarial drug resistance, Africa, malaria, drug deployment, treatment effectiveness
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
Related articles in JEB:
This article has been cited by other articles:
|
|
 |
|
  H. HOPKINS, W. KAMBALE, M. R. KAMYA, S. G. STAEDKE, G. DORSEY, and P. J. ROSENTHAL COMPARISON OF HRP2- AND pLDH-BASED RAPID DIAGNOSTIC TESTS FOR MALARIA WITH LONGITUDINAL FOLLOW-UP IN KAMPALA, UGANDA Am J Trop Med Hyg, June 1, 2007; 76(6): 1092 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. ONWUJEKWE, J. OJUKWU, N. EZUMAH, B. UZOCHUKWU, N. DIKE, and E. SOLUDO SOCIO-ECONOMIC DIFFERENCES IN PREFERENCES AND WILLINGNESS TO PAY FOR DIFFERENT PROVIDERS OF MALARIA TREATMENT IN SOUTHEAST NIGERIA. Am J Trop Med Hyg, September 1, 2006; 75(3): 421 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Weber Appropriate Use of Antimicrobial Drugs: A Better Prescription Is Needed JAMA, November 9, 2005; 294(18): 2354 - 2356. [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Hastings, J. D. Maguire, M. J. Bangs, P. A. Zimmerman, J. C. Reeder, J. K. Baird, and C. H. Sibley Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System Antimicrob. Agents Chemother., February 1, 2005; 49(2): 733 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. KACHUR, R. A. KHATIB, E. KAIZER, S. S. FOX, S. M. ABDULLA, and P. B. BLOLAND ADHERENCE TO ANTIMALARIAL COMBINATION THERAPY WITH SULFADOXINE-PYRIMETHAMINE AND ARTESUNATE IN RURAL TANZANIA Am J Trop Med Hyg, December 1, 2004; 71(6): 715 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. HANSON PUBLIC AND PRIVATE ROLES IN MALARIA CONTROL: THE CONTRIBUTIONS OF ECONOMIC ANALYSIS Am J Trop Med Hyg, August 1, 2004; 71(2_suppl): 168 - 173. [Abstract] [Full Text] [PDF]
|
|
